2010 AnnuAl REpoRT - Ciberdem
2010 AnnuAl REpoRT - Ciberdem
2010 AnnuAl REpoRT - Ciberdem
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Principal Investigator: Escolà Gil JC<br />
Associate investigators: Blanco Vaca F, Julve J<br />
Scientific collaborations within CIBERDEM<br />
Characterization of low HDL syndrome in type 2 diabetes<br />
LOWHDL: 2009-<strong>2010</strong><br />
Coordinator: Lluís Masana<br />
CIBERDEM groups: F Blanco Vaca, R Carmena, X Correig,<br />
L Masana, M Vázquez Carrera<br />
Cooperative population and database studies for genetic<br />
association analysis in T2DM and related traits<br />
INGENFRED: 2009-<strong>2010</strong><br />
Coordinator: Felipe Javier Chaves<br />
CIBERDEM groups: F Blanco Vaca, R Carmena, M Serrano<br />
Ríos, F Soriguer<br />
CIBERDEM Biobank<br />
Coordinator: A Novials<br />
CIBERDEM Biobank Nodes: F Blanco Vaca, R Gomis, A<br />
Novials, J Vendrell, L Masana, L Castaño, M Serrano Ríos,<br />
F Soriguer, R Carmena<br />
Clinical trials<br />
INSPIRE ME/IAA. International Study of Intra-abdominal<br />
Adiposity and its Relationships with Cardiometabolic Risk/<br />
Intra-abdominal Adiposity. Phase IV<br />
Sanofi-Aventis: 2007-<strong>2010</strong><br />
Researcher: Antonio Pérez<br />
HOSMIDIA. Manejo de la diabetes mellitus tipo 2 durante<br />
la hospitalización: eficacia y factibilidad de las pautas<br />
fisiológicas de insulinoterapia. Phase IV<br />
Sanofi-Aventis: 2008-<strong>2010</strong><br />
Coordinator: Antonio Pérez<br />
HINTHER. Manejo de la hiperglucemia en los hospitales:<br />
eficacia de las pautas administradas de insulina más<br />
fisiológicas. Phase IV<br />
Sanofi-Aventis: 2009-<strong>2010</strong><br />
Coordinator: Antonio Pérez ■<br />
HDL inhibits LDL oxidative modification and inflammation.<br />
58 CibeRdem
Change language